In September, The Cancer History Project is inviting contributors to discuss the turning points of oncology—the people, research, discoveries, and moments in history that broke the mold.
In August, the Cancer History Project is highlighting oral histories, and is continuing to conduct oral histories with people who have made important contributions to oncology—along with patients who have shared their stories with us.
As Jerome Yates reflects on starting up the University of Vermont Cancer Center in the early 1970s, he quotes Joe Simone: “When you’ve seen one cancer center, you’ve seen one cancer center.”
In July, The Cancer History Project is focusing on the founders of cancer centers. Joseph R. Bertino was the founding director of Yale Cancer Center, who served in that role from 1973 to 1975 and remained at Yale through 1986.
In July, the Cancer History Project is highlighting the founders of cancer centers and cancer organizations, including John Ultmann, founding director of University of Chicago Cancer Research Center, now University of Chicago Medicine Comprehensive Cancer Center—and the first subscriber to The Cancer Letter.
Following the Supreme Court’s June 24 ruling on Dobbs v. Jackson Women’s Health, the Cancer History Project has created a timeline of the regulatory history of women’s reproductive rights based on news stories from The Cancer Letter that track the impact of “pro-life” policies on cancer research and cancer care.
In July, the Cancer History Project will be highlighting the founding—and founders—of oncology’s institutions. Duke Cancer Institute became an NCI-designated cancer center in 1973, two years after the signing of the National Cancer Act of 1971.
The Cancer History Project is highlighting survivor stories throughout the month of June, which we jumpstarted with interviews conducted by guest editor Deborah Doroshow, assistant professor of medicine at Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai.
Soon after Dave Boule was diagnosed with polycythemia vera in 2006, he had a hunch that there were better treatment options out there.
At 25, Elizabeth Carner was diagnosed with stage 4 colon cancer.
